Novo Nordisk has bolstered its pipeline by paying $340 million upfront for rights to an Omeros Corp drug with potential across a range of rare blood and kidney diseases. The agreement – which could be ...
Takeda has partnered with China's Innovent Biologics for a pair of late-stage cancer therapies, in a deal that includes an upfront payment of $1.2 billion and could be worth up to $11.4 billion. The ...
9 x 15.3 in. (22.9 x 38.9 cm.) Subscribe now to view details for this work, and gain access to over 18 million auction results. Purchase One-Day Pass ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback